← Back to headlines
Kodiak Stock Rises on Positive Diabetic Retinopathy Trial Results
Kodiak Sciences saw its stock climb after announcing positive results from a late-stage clinical trial for its diabetic retinopathy therapy.
26 Mar, 11:04 — 26 Mar, 11:04
Sources
Showing 1 of 1 sources
